Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Tessa Kerre

Awards & Distinctions

Results : ALL ( 14 )

As Administrative supervisor

01 April 2021 → 26 September 2021

Improving prevention and treatment strategies concerning opportunistic infections in immunocompromised hematologic patients

Doctoral researcher: Robina Aerts

As PhD Supervisor

11 December 2009 → 08 April 2015

Doctoral project Stijn Vanhee

Doctoral researcher: Stijn Vanhee

22 February 2024 → 21 September 2025

Drug response profiling of T-cell acute lymphoblastic leukemia to optimize salvage therapeutic strategies for refractory/relapsed patients

Doctoral researcher: Hannah Van Steenberge

15 March 2023 → 21 September 2025

Early diagnosis and treatment of immune-mediated ocular surface disease.

Doctoral researcher: Dimitri Roels

15 February 2021 → 15 May 2023

Innate immune sensors balance infection surveillance and autoinflammation

Doctoral researcher: Leslie Naesens

21 November 2022 → 21 September 2025

Optimization of CD70 targeted T-cell therapy for solid and hematologic malignancies

Doctoral researcher: Lucas Deseins

18 September 2023 → 21 September 2025

Targeting the micro-environment in acute lymphoblastic leukemia

Doctoral researcher: Wouter Sleeckx

As Promotor

15 July 2019 → 15 May 2021

Funding: Regional and community funding: Industrial Research Fund

01 January 2015 → 31 December 2018

Treatment of minimal residual disease positive acute myeloid leukemia patients

Funding: Funding by bilateral agreement (private and foundations)

01 January 2024 → 31 December 2025

Unraveling the impact of Shared Reading on the wellbeing of patients in long-term hospital care

Funding: Regional and community funding: Special Research Fund

As Copromotor

01 November 2023 → 31 October 2026

Chimeric antigen receptor unconventional T cell therapy (CAR-uT) for the treatment of solid tumors

Fellow: Stijn De Munter

Funding: Research Foundation - Flanders (FWO)

01 January 2020 → 31 December 2030

Digital innovation for man and society

Funding: Regional and community funding: Special Research Fund

01 October 2023 → 30 September 2027

Drug response profiling of T-cell acute lymphoblastic leukemia to optimize salvage therapeutic strategies for refractory/relapsed patients

Fellow: Hannah Van Steenberge

Funding: Regional and community funding: Special Research Fund

01 November 2023 → 31 October 2027

Optimisation of CD70-targeted adoptive cell therapy

Fellow: Lucas Deseins

Funding: Research Foundation - Flanders (FWO)